Atomi Financial Group, Inc. Cytosorbents Corp Transaction History
Atomi Financial Group, Inc.
- $1.98 Trillion
- Q4 2024
A detailed history of Atomi Financial Group, Inc. transactions in Cytosorbents Corp stock. As of the latest transaction made, Atomi Financial Group, Inc. holds 27,443 shares of CTSO stock, worth $33,206. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,443
Previous 34,292
19.97%
Holding current value
$33,206
Previous $51.4 Million
51.45%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CTSO
# of Institutions
56Shares Held
16.4MCall Options Held
15.4KPut Options Held
0-
Avenir Corp Washington, DC3.09MShares$3.74 Million0.29% of portfolio
-
Skylands Capital, LLC2.78MShares$3.37 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.36 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$2.04 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.25MShares$1.51 Million0.18% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $52.7M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...